Registry Study on "Control Nocturnal Hypertension to Reach the Target "

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50-79
SponsorShanghai Institute of Hypertension

About this trial

Ambulatory blood pressure monitoring (ABPM) is a major innovation in the history of hypertension diagnosis. In clinical practice, the most well established indication for using ABPM is to identify patients who have high BP readings in the office but normal readings during usual daily activities outside of this setting or vice versa, and to identify varying 24-h BP profiles. However, in recent years, there has been increasing interest in BP values during sleep, and nocturnal BP is now recognized to be superior to daytime BP in predicting fatal and nonfatal cardiovascular events (stroke, myocardial infarction, and cardiovascular death), especially in medicated patients.

The current direction in the management of hypertension is toward earlier and lower BP control for 24 hours, including the nocturnal and morning periods. Therefore, it may be of great significance to pay attention to the management of nocturnal blood pressure so as to reduce the increased cardiovascular risks.

Information of nocturnal hypertensive patients defined by ABPM was prospectively registered nationwide, and then to investigate whether there was difference in cardiovascular prognosis according to the control of ambulatory nocturnal blood pressure.

Eligibility criteria

Qualifiers

Age 50-79 years old

Clinical diagnosed hypertension with the use of antihypertensive drugs

Nocturnal hypertension ( nocturnal systolic blood pressure ≥ 130 mmHg and/or nocturnal diastolic blood pressure ≥ 80 mmHg)

A 24-hour ambulatory blood pressure monitoring was performed with validated equipment.

Disqualifiers

Without antihypertensive drug use

Hospitalized hypertension patients

Non-compliant patient

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

4,500 Participants
are grouped into 2 trial groups